Eli Lilly Beats Generic Cancer Drug Again At Fed. Circ.
The Federal Circuit has handed Eli Lilly another win in its efforts to block generic-drug manufacturers from rivaling its blockbuster cancer treatment drug Alimta, rejecting an argument from Apotex that Eli...To view the full article, register now.
Already a subscriber? Click here to view full article